Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Praxis Precision Medicines is a biopharmaceutical company focused on developing therapies for central nervous system disorders, particularly epilepsy and movement disorders. Utilizing genetic insights, its platforms create targeted small molecules and antisense oligonucleotides. The company advances precision medicines through clinical trials, leveraging collaborations and proprietary technologies to address unmet needs in neurological conditions with high patient burden.
This description was generated via AI from an annual report. Updated about 1 year ago.